# KCNG2

## Overview
The KCNG2 gene encodes the protein potassium voltage-gated channel modifier subfamily G member 2, which is a part of the voltage-gated potassium channel family. This protein functions as a modifier subunit, specifically within the Kv6 family, and plays a crucial role in modulating the activity of other potassium channels. Unlike typical pore-forming α-subunits, KCNG2 acts as an electrically silent γ-subunit, influencing the electrophysiological properties of the channel complex when coexpressed with α-subunits (Fantozzi2006Bone). Structurally, the KCNG2 protein comprises six transmembrane segments and forms tetramers, which can be either homotetrameric or heterotetrameric, contributing to its functional diversity (Grizel2014Mechanisms). The protein is involved in critical cellular processes, particularly in neurons and muscle cells, where it affects cellular excitability and signaling (Fantozzi2006Bone). Dysregulation or mutations in the KCNG2 gene have been linked to neurological disorders, highlighting its significance in maintaining neuronal stability and function.

## Structure
The KCNG2 gene encodes a protein that is part of the voltage-gated potassium channel family, specifically the modifier subfamily G. These channels typically consist of six transmembrane segments (S1-S6), with a pore-forming region located between segments S5 and S6 (Goldin2007Neuronal). The protein structure includes a voltage-sensing domain formed by segments S1-S4 and a pore domain formed by segments S5-S6, which includes a selective filter and a channel gate (Grizel2014Mechanisms). 

The KCNG2 protein can form tetramers, contributing to its quaternary structure, which is a common feature among voltage-gated potassium channels (Grizel2014Mechanisms). These tetramers can be either homotetrameric or heterotetrameric, allowing for functional diversity (Grizel2014Mechanisms). 

Post-translational modifications, such as phosphorylation, may regulate the function of the KCNG2 protein, although specific details on these modifications are not provided in the context (Fantozzi2006Bone). The KCNG2 gene is part of the Kv6 family, which is known for its role in modulating the activity of other potassium channels (Grizel2014Mechanisms). However, specific details on the primary, secondary, or tertiary structures of KCNG2 are not available in the provided context.

## Function
KCNG2 encodes a protein that is part of the voltage-gated potassium channel family, specifically the modifier subfamily G. This protein functions as an electrically silent γ-subunit that modulates the activity of functional pore-forming α-subunits of voltage-gated potassium (K V) channels. When coexpressed with these α-subunits, KCNG2 can alter the electrophysiological or biophysical properties of the tetrameric channel complex, thereby influencing the flow of potassium ions across cell membranes (Fantozzi2006Bone). This modulation is crucial for maintaining cellular excitability and signaling, particularly in neurons and muscle cells.

In human pulmonary artery smooth muscle cells (PASMC), KCNG2 plays a role in modulating the function of K V channels, which are involved in processes such as hypoxic pulmonary vasoconstriction and cell proliferation. The expression of KCNG2 is significantly downregulated by Bone Morphogenetic Protein-2 (BMP-2), suggesting a regulatory pathway that may impact cell proliferation and survival through interactions with c-Myc protein expression (Fantozzi2006Bone). This indicates that KCNG2 is involved in critical cellular processes that affect the physiological function of smooth muscle cells in the pulmonary artery.

## Clinical Significance
Mutations or dysregulation of the KCNG2 gene can lead to significant clinical implications, particularly in the context of neurological disorders. KCNG2 encodes a protein that is part of the voltage-gated potassium channel family, which is essential for maintaining neuronal excitability and stability of the membrane potential. Alterations in the expression or function of KCNG2 can disrupt normal neuronal signaling, potentially resulting in conditions such as epilepsy or other channelopathies. These disorders arise due to the impaired regulation of potassium ion flow, which is critical for the proper functioning of neurons. The impact of KCNG2 mutations on neuronal signaling underscores its importance in maintaining the delicate balance required for normal brain activity. As such, understanding the role of KCNG2 in these conditions is crucial for developing targeted therapeutic strategies to manage or mitigate the effects of its dysregulation.


## References


[1. (Grizel2014Mechanisms) A. V. Grizel, G. S. Glukhov, and O. S. Sokolova. Mechanisms of activation of voltage-gated potassium channels. Acta Naturae, 6(4):10–26, December 2014. URL: http://dx.doi.org/10.32607/20758251-2014-6-4-10-26, doi:10.32607/20758251-2014-6-4-10-26. This article has 44 citations and is from a peer-reviewed journal.](https://doi.org/10.32607/20758251-2014-6-4-10-26)

[2. (Goldin2007Neuronal) Alan L. Goldin. Neuronal Channels and Receptors, pages 43–58. Elsevier, 2007. URL: http://dx.doi.org/10.1016/B978-012369509-3.50006-8, doi:10.1016/b978-012369509-3.50006-8. This article has 4 citations.](https://doi.org/10.1016/B978-012369509-3.50006-8)

[3. (Fantozzi2006Bone) Ivana Fantozzi, Oleksandr Platoshyn, Ada H. Wong, Shen Zhang, Carmelle V. Remillard, Manohar R. Furtado, Olga V. Petrauskene, and Jason X.-J. Yuan. Bone morphogenetic protein-2 upregulates expression and function of voltage-gated k+channels in human pulmonary artery smooth muscle cells. American Journal of Physiology-Lung Cellular and Molecular Physiology, 291(5):L993–L1004, November 2006. URL: http://dx.doi.org/10.1152/ajplung.00191.2005, doi:10.1152/ajplung.00191.2005. This article has 41 citations.](https://doi.org/10.1152/ajplung.00191.2005)